Cargando…
Early response to JAK inhibitors on central sensitization and pain catastrophizing in patients with active rheumatoid arthritis
OBJECTIVES: To evaluate the effect of 4 weeks of treatment with Janus kinase inhibitors (JAKis) on central sensitization (CS) and pain catastrophizing, and to determine the pain-related variables predictive of disease activity improvement, in patients with active rheumatoid arthritis (RA). METHODS:...
Autores principales: | Salaffi, Fausto, Carotti, Marina, Farah, Sonia, Ceccarelli, Luca, Giovagnoni, Andrea, Di Carlo, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135884/ https://www.ncbi.nlm.nih.gov/pubmed/35505266 http://dx.doi.org/10.1007/s10787-022-00995-z |
Ejemplares similares
-
A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease
por: Tardella, Marika, et al.
Publicado: (2022) -
The value of ultrasound and magnetic resonance imaging scoring systems in explaining handgrip strength and functional impairment in rheumatoid arthritis patients: a pilot study
por: Salaffi, Fausto, et al.
Publicado: (2022) -
Quantification of sarcopenia in patients with rheumatoid arthritis by measuring the cross-sectional area of the thigh muscles with magnetic resonance imaging
por: Salaffi, Fausto, et al.
Publicado: (2023) -
Handgrip Strength Features in Rheumatoid Arthritis Patients Assessed Using an Innovative Cylindrical-Shaped Device: Relationships With Demographic, Anthropometric and Clinical Variables
por: Salaffi, Fausto, et al.
Publicado: (2021) -
Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression
por: Tardella, Marika, et al.
Publicado: (2021)